PMC:7195088 / 30426-30627 JSONTXT

Annnotations TAB JSON ListView MergeView

    LitCovid-PD-MONDO

    {"project":"LitCovid-PD-MONDO","denotations":[{"id":"T158","span":{"begin":144,"end":152},"obj":"Disease"}],"attributes":[{"id":"A158","pred":"mondo_id","subj":"T158","obj":"http://purl.obolibrary.org/obo/MONDO_0100096"}],"text":"ethylprednisolone plus umifenovir vs. thalidomide plus inhaled alpha interferon plus methylprednisolone plus umifenovir in patients with severe COVID-19. Double-blind RCT (NCT04273581, not yet recruiti"}

    LitCovid-PD-CHEBI

    {"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T406","span":{"begin":23,"end":33},"obj":"Chemical"},{"id":"T407","span":{"begin":38,"end":49},"obj":"Chemical"},{"id":"T408","span":{"begin":63,"end":68},"obj":"Chemical"},{"id":"T409","span":{"begin":69,"end":79},"obj":"Chemical"},{"id":"T410","span":{"begin":85,"end":103},"obj":"Chemical"},{"id":"T411","span":{"begin":109,"end":119},"obj":"Chemical"}],"attributes":[{"id":"A406","pred":"chebi_id","subj":"T406","obj":"http://purl.obolibrary.org/obo/CHEBI_134730"},{"id":"A407","pred":"chebi_id","subj":"T407","obj":"http://purl.obolibrary.org/obo/CHEBI_9513"},{"id":"A408","pred":"chebi_id","subj":"T408","obj":"http://purl.obolibrary.org/obo/CHEBI_30216"},{"id":"A409","pred":"chebi_id","subj":"T409","obj":"http://purl.obolibrary.org/obo/CHEBI_52999"},{"id":"A410","pred":"chebi_id","subj":"T410","obj":"http://purl.obolibrary.org/obo/CHEBI_6888"},{"id":"A411","pred":"chebi_id","subj":"T411","obj":"http://purl.obolibrary.org/obo/CHEBI_134730"}],"text":"ethylprednisolone plus umifenovir vs. thalidomide plus inhaled alpha interferon plus methylprednisolone plus umifenovir in patients with severe COVID-19. Double-blind RCT (NCT04273581, not yet recruiti"}